Affordable Insulin Now Act · House · Mar 31, 2022 · 232–193
Cap insulin at $35 for everyone
Share voting the stated Pharma and health care position (nay)
46%
$10K+: 177 of 385 covered members
vs
40%
Below $10K: 16 of 40 covered members
Compare within each recorded party
Democrats: $10K+ 0% (0/196); below $10K 0% (0/24).
Republicans: $10K+ 94% (177/189); below $10K 100% (16/16).
Party comes from Voteview’s member record for the roll call’s Congress and may not capture changes within that Congress. Party splits do not adjust for tenure, committee roles or the mix of selected votes. Small groups can produce unstable percentages.
$201K
average traced funding, with industry; 193 covered members
$215K
average traced funding, against industry; 232 covered members
0
voting members excluded for unavailable coverage
$10K+, voted with industry
- Brett Guthrie$2.2M
- Jason Smith$1.3M
- John Joyce$1.2M
- Gus Bilirakis$1.1M
- Darin LaHood$980K
$10K+, voted against industry
- Frank Pallone$1.6M
- Richard Neal$1.5M
- Richard Hudson$1.2M
- Raul Ruiz$1.2M
- Terri Sewell$1.1M
Capped out-of-pocket insulin costs at $35 a month in private plans as well as Medicare. Passed the House 232–193; the Senate only kept the Medicare cap. This is a retrospective comparison. Funding includes covered 2020–2026 election cycles and may have arrived after the vote. It does not measure whether money changed a vote. 0 voting members excluded for unavailable coverage. Threshold: $10K in traced funding.
The full detail →